Cupron Performance Additives, a provider of proprietary cooper-based specialty chemical formulations, has closed the first tranche of its Series A Preferred Stock financing and made a strategic appointment to its board of directors.
 
The newly secured funds will enable Cupron to accelerate its transition into a specialty chemical company serving as the ingredient  for personal care and hygiene brands. The capital will support expanded product development, bolster technical support for commercial partners and grow Cupron’s presence in the market as a go-to provider of advanced copper-based solutions.
 
The company has recently expanded its sales and development team to support growing demand. It has also named Mark Miller to its Board of Directors. An executive with more than 25 years of experience in advanced materials and specialty chemicals, Miller brings deep commercial and operational expertise to Cupron. He previously held leadership roles at Lonza (now Arxada), BASF, and most recently served as president and COO of Nagase Specialty Materials.

“Mark has built and led commercial organizations at the intersection of science and consumer product innovation,” says Chris Andrews, CEO of Cupron. “His insight into scaling specialty chemical solutions, especially in hygiene and microbial control, will be a tremendous asset as we expand our partnerships and bring new Cupron-enhanced products to market.”

Cupron’s patented copper-based formulations deliver cost-effective, built-in antimicrobial, personal care, and material enhancement functionality across a broad range of product categories. The company’s partners currently have Cupron-enhanced™ technologies in market or in development across sectors including: Personal Care & Hygiene, Medical Devices, Textiles, Plastics & Solids, Coatings, Water Infrastructure, Building & Construction, Oil & Gas, Specialty Industrial.